Synergistic pharmaceutical composition comprising aceclofenac and betamethasone for the treatment of pain in localised forms of rheumatic illnesses
AssigneesFederico Amezcua Amezcua, Carlos Amezcua Amezcua
InventorPatricia del Carmen GARCIA ARMENTA
Life of this patent
Estimating the term…
Abstract
This invention is related to a pharmaceutical composition made up by the synergic combination of a nonsteroidal anti-inflammatory analgesic such as Aceclofenac or its pharmaceutically acceptable salts and an anti-inflammatory steroid agent such as the active ingredient Betamethasone or its pharmaceutically acceptable phosphate or dipropionate salts, which are formulated in a single dosing unit for topical, intramuscular or intravenous administration, which is indicated for the treatment of the localized pain of rheumatic diseases.
Claims11
A pharmaceutical composition characterized by being the synergic combination of:
- i. an NSAID agent and/or its pharmaceutically acceptable salts,
- ii. a corticosteroid agent and/or its pharmaceutically acceptable salts,
- iii. a pharmaceutically acceptable vehicle and/or excipient,
- which are formulated in a single dosing unit for transdermal, topical, aerosol, intramuscular or intravenous administration, which is indicated for the control and treatment of diseases of rheumatic pain in mammals;
- where the NSAID is preferably aceclofenac in its basic form and the corticosteroid agent is preferably betamethasone in its phosphate or dipropionate salts.
(canceled)
(canceled)
Dependencies are inferred from the claim text.